Fed. Circ. Asks If All J&J Units Belong In Remicade IP Fight
A Federal Circuit panel on Wednesday asked a biotech firm being sued by a Johnson & Johnson unit for infringing its Remicade patent why the case falls apart if all of...To view the full article, register now.
Already a subscriber? Click here to view full article